Valuation
Is the price right?Insufficient data: 1 of 2 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Oct 31, 2026
Insufficient data: 1 of 2 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
1/1 inputs reported · High confidence
Stronger than most peers on:
Earnings-per-share growth versus other banks and insurers.
Insufficient data: 1 of 2 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
| Key ratios | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|
| Return on assets (ROA) | — | 2.7% | 2.2% | ▼ 0.5 pts |
| Return on equity (ROE) | 32.3% | 33.5% | 31.7% | ▼ 1.8 pts |
| Debt to equity | — | 0.20× | 0.20× | ▲ 0.2% |
Price history is added with the daily price update and will appear after the next one.